technetium tc 99m sestamibi has been researched along with Lung Diseases, Interstitial in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assadi, M; Bahtouee, M; Eftekhari, M; Javadi, H; Nabipour, I; Raeisi, A; Saberifard, J | 1 |
| Cox, D; Earle, L; Richard, M; Varga, J | 1 |
2 other study(ies) available for technetium tc 99m sestamibi and Lung Diseases, Interstitial
| Article | Year |
|---|---|
99mTc-MIBI Lung Scintigraphy in the Assessment of Pulmonary Involvement in Interstitial Lung Disease and Its Comparison With Pulmonary Function Tests and High-Resolution Computed Tomography: A Preliminary Study.
Topics: Adult; Female; Humans; Inflammation; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Respiratory Function Tests; Severity of Illness Index; Technetium Tc 99m Sestamibi; Tomography, X-Ray Computed | 2015 |
Abnormal uptake of Tc-99m MIBI, a novel myocardial imaging agent, in the lungs of patients with systemic sclerosis.
Topics: Coronary Disease; Dyspnea; Endothelium, Vascular; Female; Fibroblasts; Heart; Humans; Injections, Intravenous; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Mitochondria; Pilot Projects; Pulmonary Diffusing Capacity; Pulmonary Fibrosis; Radionuclide Imaging; Radiopharmaceuticals; Scleroderma, Systemic; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Total Lung Capacity; Vital Capacity | 1998 |